Ablative fractional laser treatment – practical recommendations

SONJA GRUNEWALD(1), MARC O. BODENDORF(1), JÖRN ELSNER(2), TILMAN STEINBERGER(3), JOHANNES VOGELGESANG, KATI MAYER(4), ANDREAS HILLISCH(5), STEFAN SÜNKEL(6), ROBERTO ANTENNA(7), HANS-ULRICH VOIGT(8),THEO C. STEMMLER(9), UWE PAASCH(1)

1 Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Leipzig AöR und Med. Fakultät der Universität Leipzig
2 Hautarztpraxis Prof. Dr. J. Elsner, Bremen
3 Gemeinschaftspraxis Dr. med. Tilman Steinberger und Dr. med. Johannes Vogelgesang, München
4 Hautarztpraxis Dr. med. Kati Mayer, München
5 Ordinationsgemeinschaft Dr. Reingard Hillisch und Dr. Andreas Hillisch, Eferding, Österreich
6 Praxis Dr. med. Stefan Sünkel, Starnberg
7 Dr. med. Roberto Antenna, Locarno, Schweiz
8 Dr. Hans-Ulrich Voigt, München
9 Dermatologische Gemeinschaftspraxis Dr. med. Marjatta Stemmler und Dr. med. Theo C. Stemmler, Hockenheim

KEY WORDS: Laser, fractional ablative, parameter, indications, CO2

SUMMARY:
Fractional laser therapy of chronic actinic damage of the skin has shown to be safe and effective. While there is a plethora of publications regarding  indications, results and side effects these knowledge cannot be easily transferred onto specific systems and individual patients. Therefore  recommendations have been setup in order to provide information how to use a specific system for various treatment regimens. Based on a 36 month experience with more than 500 patients the expert panel derived information for  requirements of doctors training, informed consent, parameter settings and follow-up. To date it is known that a single therapy won’t result in a sufficient treatment of chronic actinic damage of the skin. However it is not exactly known if there is an individual intrinsic remodelling capacity threshold. Therefore the concept of data collection for specific intervention and systems shall be continued to derive up to date recommendations.

[download id=”255″ format=”3″]